Athira pharma to participate in jefferies london healthcare conference

Bothell, wash., nov. 08, 2023 (globe newswire) -- athira pharma, inc.  (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that company management will participate at the jefferies london healthcare conference, taking place from november 14-16, 2023, in london. details are as follows:
ATHA Ratings Summary
ATHA Quant Ranking